Spruce Biosciences Inc
OTC:SPRB

Watchlist Manager
Spruce Biosciences Inc Logo
Spruce Biosciences Inc
OTC:SPRB
Watchlist
Price: 84 USD 0.31% Market Closed
Market Cap: 89.9m USD

Operating Margin
Spruce Biosciences Inc

-7 100%
Current
-1 594%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7 100%
=
Operating Profit
-49.5m
/
Revenue
697k

Operating Margin Across Competitors

No Stocks Found

Spruce Biosciences Inc
Glance View

Market Cap
89.9m USD
Industry
Biotechnology

Spruce Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Daly City, California and currently employs 15 full-time employees. The company went IPO on 2020-10-09. The firm is focused on developing and commercializing therapies for rare endocrine disorders. The firm's development product candidate, tildacerfont, is a non-steroidal therapy that offers disease control for patients suffering from congenital adrenal hyperplasia (CAH). Tildacerfont is a potent and selective, non-steroidal, oral, small-molecule antagonist of the corticotropin-releasing hormone receptor 1 (CRF1) receptor, which is a regulator of the production of adrenocorticotropic hormone (ACTH). Its CAHmelia-203, is a placebo-controlled, double-blind Phase IIb clinical trial in adult patients with CAH with poor disease control. Its CAHmelia-204, is a second Phase IIb clinical trial in adult patients with CAH with good disease control focused on glucocorticoid reduction. The company has also conducted two Phase IIa clinical trials of tildacerfont in adult patients with CAH on stable glucocorticoid therapy.

SPRB Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-7 100%
=
Operating Profit
-49.5m
/
Revenue
697k
What is the Operating Margin of Spruce Biosciences Inc?

Based on Spruce Biosciences Inc's most recent financial statements, the company has Operating Margin of -7 100%.

Back to Top